Internal Medicine Alert - August 30, 2006

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stephen Brunton, MD
Clinical Professor
University of California, Irvine

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Associate Editors
Eileen C. West, MD
Director
Primary Care Women's Health
Clinical Assistant Professor
Internal Medicine/Obstetrics and Gynecology;
University of Oklahoma Health Sciences Center, Oklahoma City

Joseph E. Scherger, MD, MPH
Professor
University of California, San Diego

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

William T. Elliott, MD, FACP
Chair
Formulary Committee
Northern California Kaiser Permanente;
Asst. Clinical Professor of Medicine
University of California
San Francisco

Barbara A. Phillips, MD, MSPH
Professor of Medicine
University of Kentucky;
Director
Sleep Disorders Center
Samaritan Hospital
Lexington

Malcolm Robinson, MD, FACP, FACG
Emeritus Clinical Professor of Medicine
University of Oklahoma College of Medicine Oklahoma City

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Subjects:

  • Motion and Mortality
  • Sore Points on Treating Sore Throats
  • Finally an Optimal Strategy for Diagnosing Deep Vein Thrombosis
  • PPI or Testing for Helicobacter pylori as the First Step for Patients Presenting with Dyspepsia?
  • Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®)
  • Clinical Briefs By Louis Kuritzky, MD

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens

Financial Disclosure:

Internal Medicine Alert's Editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca, and serves on the speaker's bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil. Peer reviewer Gerald Roberts, MD, and associate editors Eileen C. West, MD, Joseph E. Scherger, MD, MPH, James Chan, PharmD, PhD, and William T. Elliott, MD, FACP report no financial relationship to this field of study. Associate editor Barbara A. Phillips, MD, MSPH serves on the speaker’s bureau of Cephalon, Boehringer Ingelheim, Merck, ResMed, and GlaxoSmithKline, and is a consultant for Boehringer Ingelheim, Wyeth-Ayerst, and ResMed. Associate editor Malcolm Robinson MD, FACP, FACG serves as a consultant for TAP, Pfizer, Janssen, Eisai, J&J-Merck, and Procter & Gamble, is on the speaker's bureau of Janssen, Eli Lilly, Solvay, TAP, and Aventis, and does research for Forest Labs, Wyeth-Ayerst, AstraZeneca, and Centocor. Associate editor Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker’s bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2006 AHC Media. All rights reserved.